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ABSTRACT A family of human transforming genes, previ-
ously shown to share homology with the ras family of viral on-
cogenes, maps to three different human chromosomes. A well-
characterized mouse-human hybrid cell panel, combined with
Southern blotting, was used in this study. The transforming gene
of the T24 bladder carcinoma cell line maps to human chromo-
some 11. An oncogene isolated from the lung carcinoma cell line
SK-Calu-1 maps to human chromosome 12. The third ras-related
gene, cloned from SK-N-SH, a neuroblastoma cell line, maps to
human chromosome 1.
The study of tumorigenic RNA retroviruses has led to the dis-
covery of discrete genetic entities that are capable of trans-
forming normal cells to a state of malignant growth (1). These
DNA sequences have been termed oncogenes. Additionally,
viral oncogenes are homologous to endogenous cellular genes
(2, 3). It is widely speculated that the transforming genes of
RNA viruses represent transduced cellular genes. Recent stud-
ies support this hypothesis (4, 5). The roles of these cellular
protooncogenes in normal cell metabolism are unknown.
A second avenue of investigation, utilizing DNA-mediated
gene transfer, also has led to the cloning of oncogenic se-
quences (6-9). However, these oncogenes are isolated from
mammalian tumor cell lines, not viruses. Interestingly, many
of the oncogenes isolated in this manner are homologous to viral
oncogenes (10-13). These cellular oncogenes are mutated proto-
oncogenes (14-16). It is possible that these mutations are the
ultimate molecular cause of cellular transformation.
A number of oncogenes have been mapped to human or mouse
chromosomes (17-22). Klein (23) predicted that chromosome
alterations characteristic of certain cancers may involve rear-
rangements of cellular oncogenes, resulting in altered expres-
sion of the gene. Recent reports concerning chromosome trans-
locations affecting the c-myc or c-mos genes in Burkitt lymphoma
(24, 25), mouse plasmacytomas (26, 27), and chronic myeloid
leukemia (28) confirm this idea. The map positions of other on-
cogenes may suggest additional correlations with chromosome
changes seen in tumor cells.
In this study three human oncogenes, previously cloned from
human tumor cell lines (7, 9, 13), have been assigned chro-
mosome locations. The three genes are members of a family of
genes related to the ras family of viral oncogenes (13). The
transforming gene of the T24 bladder carcinoma cell line is closely
homologous to the oncogene of the Harvey murine sarcoma
virus, designated v-H-ras. The oncogene cloned from SK-Calu-
1, a lung carcinoma cell line, is closely homologous to the on-
cogene of the Kirsten murine sarcoma virus, designated v-K-
ras. The transforming gene of SK-N-SH, a neuroblastoma cell
line, is weakly homologous to both viral genes and encodes a
highly related protein (unpublished results). By the Southern
blot technique (29), we used cloned probes of these oncogenes
to screen a mouse-human hybrid DNA panel (30) and deter-
mined that (i) the bladder carcinoma oncogene maps to human
chromosome 11, thus confirming two earlier reports (31, 32);
(ii) the lung carcinoma oncogene maps to human chromosome
12, confirming an earlier report (33); and (iii) the transforming
gene of the neuroblastoma line maps to human chromosome 1.
MATERIALS AND METHODS
Cell Lines. Mouse-human hybrid cells were cultivated with-
out antibiotics in a-minimal essential medium containing 10%
(vol/vol) fetal bovine serum in roller bottles. Cytogenetic and
isozyme samples were taken when DNA was isolated. Mono-
layers were washed twice with saline and once with 50 mM
Tris HC1, pH 8/10 mM NaCI/10 mM EDTA at 40C. This Tris/
NaCl/EDTA buffer supplemented with 0.5% NaDodSO4 (Be-
thesda Research Laboratories) and proteinase K (100 jg/ml)
was added, followed by overnight incubation at 37°C on a roller
mill. DNA was extracted twice with redistilled phenol, twice
with chloroform/isoamyl alcohol, 24:1 (vol/vol), concentrated
in dialysis bags against polyethylene glycol 8000 (Sigma), and
exhaustively dialyzed against 10 mM Tris-HCI, pH 8/1 mM
EDTA.
Hybrid cell parents were mouse A9-human GM144 (series
AHA), mouse A9-human GM589 (series BDA), mouse A9-hu-
man 126 (series 41PT), and mouse A9-human W138 (series WA).
Subelones of hybrids were isolated by dilution plating. Genetic
analysis of hybrids included G-banding of 25-50 cells for chro-
mosome constitution and isozyme analysis. The chromosomes
and their isozyme markers as determined by starch gel or cel-
lulose acetate electrophoresis and histochemical staining, in-
cluded: chromosome 1, enolase-1 (EC 4.2.1.11), phosphoglu-
comutase-1 (EC 2.7.5.1), and peptidase-C (EC 3.4.11.-);
chromosome 2, malate dehydrogenase-1 (EC 1.1.1.37) and iso-
citrate dehydrogenase-1 (EC 1.1.1.42); chromosome 3, acylase-
1 (EC 3.5.1.14); chromosome 4, peptidase-S (EC 3.4.11.-) and
phosphoglucomutase-2 (EC 2.7.5.1); chromosome 5, hexos-
aminidase-B (EC 3.2.1.30); chromosome 6, glyoxylase-1 (EC
4.4.1.5) and malic enzyme-i (EC 1.1.1.40); chromosome 7, ,B-
glucuronidase (EC 3.2.1.31) and uridine phosphorylase (EC
2.4.2.3); chromosome 8, glutathione reductase (EC 1.6.4.2);
chromosome 9, adenylate kinase-1 (EC 2.7.4.3) and aconitase-
s (EC 4.2.1.3); chromosome 10, adenosine kinase (EC 2.7.1.20)
and glutamate-oxaloacetate transaminase (EC 2.6.1.1); chro-
mosome 11, lactate dehydrogenase-A (EC 1.1.1.27); chromo-
some 12, triosephosphate isomerase (EC 5.3.1.1), peptidase-B
(EC 3.4.11.-), and lactate dehydrogenase-B (EC 1.1.1.27);
chromosome 13, esterase-10 (EC 3.1.1.1); chromosome 14, nu-
cleoside phosphorylase (EC 2.4.2.1); chromosome 15, man-
nosephosphate isomerase (EC 5.3.1.8), pyruvate kinase-3 (EC
2.7.1.40), and hexosaminidase-A (EC 3.2.1.30); chromosome
Abbreviation: kb, kilobase pairs.
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16, adenosine phosphoribosyltransferase (EC 2.4.2.7); chro-
mosome 17, galactokinase (EC 2.7.1.6); chromosome 18, pep-
tidase-A (EC 3.4.11.-); chromosome 19, glucosephosphate
isomerase (EC 5.3.1.9); chromosome 20, adenosine deaminase
(EC 3.5.4.4); chromosome 21, superoxide dismutase-I (EC
1. 15. 1.1); chromosome 22, aconitase-m (EC 4.2.1.3); and the X
chromosome, phosphoglycerate kinase (EC 2.7.2.3), hypoxan-
thine/guanine phosphoribosyltransferase (EC 2.4.2.8), and
glucose-6-phosphate dehydrogenase (EC 1.1.1.49).
Molecular Probes. pT24 is pBR322 with a 6.2-kilobase-pair
(kb) BamHI insert, entirely of human origin, which includes
the transforming gene of the T24 bladder carcinoma line (7).
pLRHL4 is pBR322 with a 1.2-kb HindIII/EcoRI insert ho-
mologous to the transforming gene of the SK-Calu-1 lung car-
cinoma line (13). pNP-5 contains a 1.8-kb Xba I/EcoRI frag-
ment, homologous to the transforming gene of the SK-N-SH
neuroblastoma cell line, cloned in pchtk-2 (a pBR322 derivative
containing the chicken thymidine kinase gene) (9).
Enzymes. BamHI, EcoRI, and HindIII restriction endonu-
cleases were purchased from New England BioLabs and Be-
thesda Research Laboratories and were used according to the
suppliers' instructions. Nick translations were carried out by
using a kit purchased from Amersham.
Southern Blotting and DNA Hybridization. DNA samples
(20-30 ,g) were digested with restriction endonuclease and
electrophoresed in 1% agarose gels prior to transfer by the
Southern technique (29) to nitrocellulose (Schleicher & Schuell)
or APT (aminophenyl thioether) paper (Schleicher & Schuell).
Hybridization either was done at 65-70'C for 12 hr in buffer
containing 6X NaCl/Cit (lx NaCl/Cit = 0.15 M NaCI/0.015
M Na citrate, pH 7), 2 X Denhardt's solution (1x = 0.02% poly-
vinylpyrrolidone/0.2% Ficoll/0.2% bovine serum albumin),
20 mM sodium phosphate, 10% dextran sulfate (Pharmacia),
and 100 ,g of denatured, sonicated salmon sperm DNA per ml
or was done at 42°C for 12 hr in buffer containing 5x NaCl/
Cit, 50% formamide (Macalaster Bicknell), 2X Denhardt's so-
lution, 10% dextran sulfate, and 100 ,ug of denatured, sonicated
salmon sperm DNA per ml, in both cases with 10 ng of dena-
tured, nick-translated probe added per ml. Final wash in both
cases was at 65°C with buffer containing 0.4X NaCl/Cit, 4 mM
sodium phosphate, 0.01% sodium pyrophosphate, and 0.01%
NaDodSO4 (Bio-Rad). Hybridized probe was detected by au-
toradiography.
RESULTS
Transforming Gene of the T24 Bladder Carcinoma Cell Line
Maps to Chromosome 11. Fig. 1 shows pT24 blotted against
seven BamHI-cut hybrid cell DNAs. A single band of human
DNA of approximately 7.5 kb was seen in the HeLa cell line
control track. Three hybrid DNAs, 10a3, 16e, and 3d2, also
showed the 7.5-kb human DNA band. A cross-hybridizing mouse
DNA band of 3.6 kb was seen in every hybrid DNA. This initial
screen suggested that pT24 mapped to either chromosome 11
or 12. An assignment to chromosome 11 was made when hy-
bridization was seen with the hybrid cell line Fry-i (data not
shown). This line has been obtained by selecting with the flu-
orescence-activated cell sorter for the presence of 4F2, a hu-
man cell-surface antigen that maps to chromosome 11 (34). Fry-
1 DNA is characterized as having chromosome 11 as its only
human chromosome. A restriction-fragment-length polymor-
phism was seen between Fry-i (human parent GM 126) and
HeLa DNAs (data not shown). The polymorphic nature of this
locus has been noted (7). Table 1 summarizes the hybrid panel
data for pT24.
Transforming Gene of the SK-Calu-1 Lung Carcinoma Cell
Line Maps to Chromosome 12. Hybridization of pLRHL4 to
a total of 22 hybrid DNAs (see Table 1) localized the trans-
forming gene from the lung carcinoma cell line to chromosome
12. No cross-hybridization was seen with mouse DNA under
stringent wash conditions. No polymorphisms were detected in
human DNAs. To confirm this assignment, a chromosome 12
positive control was hybridized to the hybrid panel. D12S1 is
a unique human restriction fragment previously mapped to
chromosome 12 (35). The hybridization pattern seen with D12S1
matched that seen with pLRHL4 except for two hybrid DNAs,
BDA-17b17 and 41PT2A (data not shown). Both lines are pos-
itive for the presence of pLRHL4 and negative for D12S1.
Karyotypic analysis found no evidence for chromosome 12 in
either line. Three chromosome 12 isozymes were scored, with
negative results for peptidase B, a long-arm marker, and pos-
itive results for lactate dehydrogenase B and triosephosphate
isomerase, short-arm markers, in both lines. It would appear
that, although neither hybrid line has retained an intact chro-
mosome 12, both have retained a segment of the short arm.
Taken together, the results with D12S1 confirm the assignment
of pLRHL4 to chromosome 12 and strongly suggest that this
gene resides on the short arm.
Transforming Gene of the SK-N-SH Neuroblastoma Cell
Line Maps to Chromosome 1. Fig. 2 shows pNP-5 hybridized
to nine HindIII-cut hybrid cell DNAs. A single band of human
DNA of approximately 10 kb is seen in the HeLa control track
and in three of the nine hybrid DNAs. Hybridization to a total
of 15 hybrid DNAs suggested that the neuroblastoma gene re-
sided on either chromosome 1 or chromosome 5. To distinguish
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FIG. 1. pT24 (hu-H-ras-l) hybridized to seven
BamHI-cut hybrid DNAs. Tracks: A,-BDA 10a3;
o B, BDA 17b17; C, AHA 16e; D, WAVR4d A19 F3-
2; E, AHA 3d2; F, 41PT2A; G, BDA 14b25; H,
blank; I, mouse control, A9; J, human control,
2.2 HeLa. Sizes are shown in kb. BDA 10a3, AHA 16e,
2.0 and AHA 3d2 were scored as positive for the 7.5-kb human DNA band (Hu). A mouse DNA cross-
hybridizing band of 3.6 kb is also seen (Mo).
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Table 1. Correlation of blot hybridization and chromosome status in hybrid DNAs
Blot Presence of Chromosome content of hybrid DNAs, no. of clones
Probes hybridization chromosome 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X
pT24
(hu-H-ras-1) + + 0 3 4 1 0 1 0 2 0 3 5 3 3 1 1 2 0 2 4 3 2 1 4
-
- 3 3 2 2 4 4 4 4 2 4 5 5 4 2 3 3 5 3 2 4 2 2 1
+ 2 2 3 2 1 0 1 1 2 1 0 0 1 1 2 1 0 2 3 1 2 3 4
+ - 4 2 1 4 5 3 3 1 4 1 0 2 2 3 4 3 5 3 1 2 3 3 1
Discordant 6 4 4 6 6 3 4 2 6 2 0 2 3 4 6 4 5 5 4 3 5 6 5
pLHRL4
(hu-K-ras-2) + + 1 5 8 4 2 3 0 2 0 5 5 8 2 4 2 2 2 4 6 6 6 3 9
-
- 4 6 2 4 5 5 5 5 7 7 5 6 3 6 5 5 5 6 5 5 3 3 3
+ 2 1 2 2 1 2 1 0 0 0 2 0 3 0 1 1 1 1 2 2 3 3 4
+ - 7 2 0 4 6 6 8 5 7 3 4 0 4 3 7 3 3 6 4 4 2 0 0
Discordant 9 3 2 6 7 8 9 5 7 3 6 0 7 3 8 4 4 7 6 6 5 3 4
pNP-5
(hu-N-ras-1) + + 7 1 4 4 4 1 1 0 0 0 0 0 1 0 2 1 2 2 2 3 3 3 4
-
- 11 5 2 5 11 5 8 3 8 5 4 4 5 6 7 7 6 7 6 6 4 2 2
+ 0 5 6 2 1 4 0 2 1 5 5 5 3 3 1 2 1 3 4 4 4 3 8
+ - 0 1 0 0 3 3 2 4 2 4 4 1 2 1 2 2 2 2 1 1 0 1 0
Discordant 0 6 6 2 4 7 2 6 3 9 9 6 5 4 3 3 3 5 5 5 4 4 8
Hybrid lines with inconclusive karyotype and isozyme data for a particular chromosome are not included in this table.
between these two possibilities, a series of chromosome 5+/
chromosome 5- hybrids were created by subjecting chromo-
some 5+ hybrid cells to selection with diphtheria toxin. Diph-
theria toxin sensitivity maps to human chromosome 5 (36); hence,
surviving cells should be chromosome 5. This can be verified
by isozyme and karyotype analysis. Three pairs of chromosome
5+/chromosome 5- hybrid cell DNAs obtained in this manner
were hybridized to pNP-5. The resulting band pattern (Fig. 3)
did not correlate with chromosome 5. This pattern did correlate
with the presence or absence of human chromosome 1. There-
fore, we assigned the neuroblastoma gene to chromosome 1.
Table 1 summarizes the hybrid panel data for pNP-5.
DISCUSSION
We have shown that three members of a ras-related family of
human oncogenes map to three different chromosomes. This
family of genes may be quite large: v-H-ras and v-K-ras each
have two human homologs (37). The transforming gene of the
T24 bladder carcinoma cell line appears to be the human homo-
log designated hu-H-ras-1 (13). The assignment of this gene to
chromosome 11 confirms the work of two other laboratories (31,
32). De Martinville et aL (32) have localized the gene to the short
arm of chromosome 11 through the use of hybrids containing
translocated human chromosomes. It has been suggested, based
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on this localization, that this gene plays a role in the Wilm tu-
mor/aniridia syndrome (38). Studies at the molecular level should
reveal any correlation between these diseases and structural
changes in this gene. The transforming gene of the SK-Calu-1
lung carcinoma cell line corresponds to the human homolog
designated hu-K-ras-2 (13). Cytologically detectable changes in
chromosome 12 have only been seen infrequently in human
malignancies (39). It is interesting that hu-H-ras-1 and hu-K-
ras-2 map to the short arms of chromosomes 11 and 12. These
chromosomes may be related by a duplication event-for ex-
ample, the gene for lactate dehydrogenase A, LDH-A, resides
on the short arm of chromosome 11, and LDH-B is found on
the short arm of chromosome 12 (30). The transforming gene
of the SK-N-SH cell line, termed hu-N-ras-1, represents a third
branch of this family (9, 13). There appear to be additional hu-
man genes closely related to hu-N-ras-1 (13). It may be relevant
that chromosome 1 anomalies have been noted in several hu-
man neuroblastomas (40, 41). In addition, chromosome 1 changes
occur frequently in various hematologic neoplasias (42). It re-
mains to be determined if the additional genes of this family
are dispersed throughout the genome or if members of a par-
ticular branch are clustered together.
The three ras-related human transforming genes mapped here
have been isolated frequently from tumor lines and solid tu-
K
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9.4 6U_ - . pNr FIG. 2. pNP-5 (hu-N-ras-1) hybridized to nine
HindiII-cut hybrid DNAs. Tracks: A, human control,
HeLa; B, mouse control, A9; C, BDA 17bl7; D, BDA
17bl7-6; E, BDA 17bl7-3; F, AHA 16e; G, AHA 3d2; H,
BDA 14b25; I, 41PT2A; J, BDA lOa3; K, AHA lla. Sizes
are shown in kb. BDA 17bl7, BDA 17b17-6, and BDA
14b25 were scored as positive for the 10-kb human DNA
band.
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FIG. 3. pNP-5 (hu-N-ras-1) hybridized to three pairs of diphtheria
toxin-selected chromosome 5+/chromosome 5- EcoRI-cut DNAs. Tracks:
A, human control, HeLa; B, BDA 10a3; C, BDA 10a3 DT; D, BDA 17b17-
1; E, BDA 17b17-1 DT; F, AHA 16e; G, AHA 16e DT. Sizes are shown
in kb. BDA 10a3, BDA 17b17-1, and AHA 16e are positive for chro-
mosome 5. BDA 10a3 DT, BDA 17b17-1 DT, and AHA 16e DT are
negative for chromosome 5. BDA 17b17-1 and BDA 17b17-1 DT were
scored as positive for the 7.0-kb human DNA band.
mors (43). This may be due to an inherent bias in the NIH 3T3
assay or may reflect an important role of this family of genes
in human carcinogenesis.
Note Added in Proof. The hu-N-ras-1 gene locus has subsequently been
localized by M. Rabin in our laboratory to 1 cen -* p21 by hybridization
in situ of an N-ras specific probe to human metaphase chromosomes.
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